Associate Director of the Melanoma Program at the Mass General Cancer Center & Associate Professor of Medicine at Harvard Medical School

The past decade has seen a remarkable number of therapies lead to a dramatic improvement in survival for patients with advanced melanoma. Targeted therapies and immunotherapies are responsible for this improvement, but they can also impact survivorship. Dr. Sullivan will review key aspects of melanoma survivorship and potential issues related to these therapies, surgery, and radiation.

Giselle Perez, PhD
Clinical Health Psychologist at Mass General Hospital, Director of Adolsecent & Young Adult Research, Director of the MGH Mind Body Program for Cancer Survivors, & Assistant Professor of Psychology at Harvard Medical School

Dr. Perez will discuss the importance of attending to the post-treatment psychosocial needs of patients with cancer. She will summarize the Cancer Center’s current efforts to improve patients’ coping and resiliency after cancer treatment. She will also present next steps, including expanding clinical groups for adolescent and young adult survivors, metavivors, and patients who are Spanish-speaking.